Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

    Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

    Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

    We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

    1. Home

    2. Perspectives

    3. Current Challenges in Clinical Diagnostic Testing
    Digitalizing healthcare

    Current Challenges in Clinical Diagnostic Testing

    4min
    Linda Brookes
    Published on July 19, 2019

    Healthcare organizations are under pressure to cut costs by reducing the volume of inappropriate, unnecessary, redundant, or obsolete tests.

    Integrating and Streamlining Testing

    Testing Outside the Core Laboratory

    Harmonization of Lab Test Results

    Atellica® Solution1

    Atellica® Solution1

    Avoiding Inappropriate Testing

    Future Directions

    Atellica PM 1.0 Software2

    Atellica Process Manager2

    The Siemens Healthineers Walpole Facility.

    The Siemens Healthineers Walpole Facility

    By Linda Brookes
    Linda Brookes is a freelance medical writer and editor based in New York and London with a record of working for a wide range of international clients and publications in the healthcare and pharmaceutical fields.

    1. Johnson AS. Point-of-care or clinical lab INR for anticoagulation monitoring: Which to believe? Clin Lab News. April 1, 2017. https://www.aacc.org/publications/cln/articles/2017/april/point-of-care-or-clinical-lab-inr-for-anticoagulation-monitoring-which-to-believe.

    2. Hoerger TJ, Wittenborn JS, Young W. A cost-benefit analysis of lipid standardization in the United States. Prev Chronic Dis. 2011;8:A136.

    3. Song Z, Safran DG, Landon BE, et al. Health care spending and quality in year 1 of the alternative quality contract. N Engl J Med. 2011;365:909-18.

    4. Zhi M, Ding EL, Theisen-Toupal J, et al. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One. 2013;8:e78962.

    5. Taylor JR, Thompson PJ, Genzen JR, et al. Opportunities to enhance laboratory professionals' role on the diagnostic team. Lab Med. 2017;48:97-103.

    6. Ferraro S, Panteghini M. The role of laboratory in ensuring appropriate test requests. Clin Biochem. 2017;50:555-61.

    1. DCA HbA1c test kit 10698915 (an aid to diagnose diabetes and identify patients at risk for developing diabetes) is not available for sale in the U.S. Product availability varies by country.

    2. Product availability varies by country.

    3. Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.

    1. The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.